Sci Simple

New Science Research Articles Everyday

# Biology # Cell Biology

The Role of Endocytosis in Cancer and Immune Response

Endocytosis shapes cellular functions and immune interactions in cancer.

Henri-François Renard, S. Xu, A. Buridant, T. Hirsch, M. Shafaq-Zadah, E. Dransart, B. Ledoux, L. Johannes, P. van der Bruggen, P. Morsomme

― 5 min read


Endocytosis: Key to Endocytosis: Key to Cancer Defense cancer treatment strategies. Endocytosis impacts immune response and
Table of Contents

Endocytosis is a process by which cells take in substances from their surroundings. This can include nutrients, signals from other cells, or even components of the cell membrane itself. When a cell wants to bring something inside, it forms a pocket in its outer membrane. This pocket then pinches off to create a small bubble, or vesicle, that carries the materials into the cell's interior.

Types of Endocytosis

There are two main types of endocytosis:

  1. Clathrin-Mediated Endocytosis (CME): This is the more common type, where a protein called clathrin helps to shape the vesicle that carries the material into the cell.

  2. Clathrin-Independent Endocytosis (CIE): This type occurs without clathrin and involves different mechanisms. CIE is less understood than CME, and scientists continue to explore how it works.

Importance of Endocytosis

Endocytosis is crucial for many cell functions. By internalizing signaling molecules, cells can respond to their environment and communicate with one another. It also helps maintain the balance of the cell membrane by recycling membrane components. In addition, endocytosis is essential for transporting proteins and other materials within the cell.

Two Key Pathways After Endocytosis

Once a substance is taken in through endocytosis, it goes into an early endosome. From there, two main pathways can occur:

  1. Degradation: In this pathway, the substance is sent to lysosomes, which act like the cell's waste disposal system. The contents are broken down and recycled or eliminated.

  2. Recycling: Some materials are returned to the cell surface to be used again. This recycling can be done through specific pathways involving proteins that help direct the vesicles back to the cell membrane.

Components of Endocytosis

Role of Endophilin A Proteins

A special group of proteins called Endophilin A (EndoA) plays a significant role in endocytosis. There are three types of Endophilin A proteins: EndoA1, EndoA2, and EndoA3. Each type is found in different tissues and has unique functions:

  • EndoA1: Mainly found in the brain.

  • EndoA2: Present in many types of tissues.

  • EndoA3: Highly expressed in the brain and testes.

Endophilins are involved in the formation of vesicles during endocytosis. They help shape the membrane, allowing it to bend and pinch off to form vesicles.

The Role of Endocytosis in Cancer

In cancer cells, endocytosis can affect how the cells interact with the immune system. Immune cells are designed to recognize and attack cancer cells. However, cancer cells often find ways to evade these attacks.

A Key Player: ALCAM

Activated Leukocyte Cell Adhesion Molecule (ALCAM) is a protein found on the surface of many cells, including cancer cells. It helps in cell communication and interactions. ALCAM can interact with immune cells and is known to play a role in forming immune synapses, which are necessary for effective immune responses.

ICAM1: Another Important Protein

Intercellular Adhesion Molecule 1 (ICAM1) is another protein that plays a vital role in immune response. Like ALCAM, ICAM1 is important for cell interactions and is often found in immune synapses.

How Endocytosis Affects Immune Responses

Internalization and Retrograde Transport

After endocytosis, proteins like ALCAM and ICAM1 can follow a retrograde transport pathway, which means they are taken from the endosome to a specialized area in the cell known as the Golgi apparatus. The Golgi helps process and transport these proteins to where they are needed.

Importance of Retromer Complex

The retromer complex is a group of proteins that helps sort and transport the internalized cargo back to the cell membrane. It plays a crucial role in ensuring that proteins like ALCAM and ICAM1 can be efficiently recycled to the cell surface, where they can participate in immune responses.

Research Findings

Recent studies suggest that Endophilin A3 is essential for the endocytosis of ALCAM and ICAM1 in cancer cells. When this protein is not functioning correctly, it can lead to reduced levels of these proteins at the cell surface, impairing the ability of immune cells to recognize and attack cancer cells.

Impact on T Cell Activation

T cells, a type of immune cell, rely on proper signaling to become activated and do their job. When the recycling of ALCAM and ICAM1 is disrupted, T cells may not receive the signals they need, leading to decreased activation and effectiveness against cancer cells.

Observations in Cancer Cell Lines

Scientists conducted experiments using melanoma cell lines derived from patients. They discovered that when EndoA3 was depleted, T cell activation was significantly reduced. This highlights the importance of EndoA3 in the endocytosis process and its contribution to shaping immune responses in cancer.

The Bigger Picture: Immune Synapse Formation

An immune synapse is the area where T cells interact with other cells, such as cancer cells. Proper formation of this synapse is critical for an effective immune response. The interplay between endocytosis, retrograde transport, and protein recycling is crucial for maintaining the structure and function of these synapses.

Compensation Mechanisms

Researchers also observed that T cells attempt to compensate for the reduced levels of immune synapse components by increasing the size of the synapse itself. However, even with larger synapses, the lack of adequate protein recruitment leads to insufficient T cell activation.

Conclusion

Endocytosis is a fundamental process that significantly impacts cellular communication and responses to external signals. In the context of cancer, understanding how endocytosis interacts with immune responses provides valuable insights into potential therapeutic strategies. By targeting specific components of endocytosis and the pathways that govern protein recycling, researchers hope to enhance the immune system's ability to recognize and defeat cancer cells. Future studies will continue to explore these intricate mechanisms, ultimately aiming to improve cancer treatment outcomes.

Original Source

Title: Clathrin-independent endocytosis and retrograde transport in cancer cells promote cytotoxic CD8 T cell activation

Abstract: Endophilin A3-mediated clathrin-independent endocytosis (EndoA3-mediated CIE) mediates the internalization of immunoglobulin-like proteins, including key immune synapse components. Here, we identify ICAM1 as a novel EndoA3-dependent cargo, alongside ALCAM. We demonstrate that both proteins subsequently undergo retromer-dependent retrograde transport to the trans-Golgi network (TGN) in cancer cells. From there, they undergo polarized redistribution to the plasma membrane, where they contribute to immune synapse formation between cancer cells and cytotoxic CD8 T cells. Disruption of EndoA3 or retromer components significantly impairs the activation of autologous cytotoxic CD8 T cells, as demonstrated by decreased cytokine production. Concomitantly, we observed a reduced localization of ICAM1 at the immune synapse, indicating impaired immune synapse integrity. Indeed, cancer cells lacking EndoA3-mediated CIE or retromer form enlarged immune synapses that fail to restore full T cell activation, suggesting a compensatory attempt by T cells to overcome the defective synapse. Together, these findings reveal that EndoA3-mediated CIE and retrograde transport act in concert in cancer cells to relocate immune synapse components via the Golgi, thereby promoting the activation of cytotoxic CD8 T cells. Our study paves the way for the design of future therapeutic strategies targeting these pathways to enhance T cell-mediated anti-tumor immunity.

Authors: Henri-François Renard, S. Xu, A. Buridant, T. Hirsch, M. Shafaq-Zadah, E. Dransart, B. Ledoux, L. Johannes, P. van der Bruggen, P. Morsomme

Last Update: 2025-01-02 00:00:00

Language: English

Source URL: https://www.biorxiv.org/content/10.1101/2024.10.28.620627

Source PDF: https://www.biorxiv.org/content/10.1101/2024.10.28.620627.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to biorxiv for use of its open access interoperability.

More from authors

Similar Articles